Company Filing History:
2 out of 55 
1 out of 4,459 
1 out of 523 
Years Active: 2004-2006
Title: The Innovative Contributions of Jonas Ekblom
Introduction
Jonas Ekblom is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of novel matrix metalloproteinases and related therapeutic applications. With a total of 4 patents to his name, Ekblom's work has the potential to impact medical treatments for conditions such as obesity and diabetes.
Latest Patents
Among his latest patents, one focuses on matrix metalloproteinase polypeptides. This invention provides genes encoding novel matrix metalloproteinases termed MMP, constructs, and recombinant host cells incorporating these genes. It also includes the MMP polypeptides encoded by the genes, antibodies to the MMP polypeptides, and methods of making and using all of the foregoing. Another significant patent relates to isolated human Site-1 Protease promoter regions. This invention includes screening methods for agents that decrease the expression of Site-1 protease, which may be useful for treating medical conditions related to obesity and diabetes.
Career Highlights
Throughout his career, Jonas Ekblom has worked with prominent companies in the biotechnology sector, including Biovitrum AB and Pfizer Corporation. His experience in these organizations has allowed him to collaborate on various innovative projects and contribute to advancements in medical research.
Collaborations
Some of his notable coworkers include Margareta Forsgren and Per Johansson. Their collaborative efforts have further enhanced the impact of Ekblom's inventions in the field.
Conclusion
Jonas Ekblom's innovative work in biotechnology, particularly in the area of matrix metalloproteinases, showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving treatments for significant health issues.